The medical device and life sciences industries move at a fast pace with major advances in technology and exponential market growth markedly pronounced in some geographies. The evolution of healthcare innovation occurs in a global market context, where binding forces such as evolving politics, reforming policies, and increasingly shifts in consumer demand, drive market growth and influence change.
In this seminar, Dr Caroline Popper will talk about cutting-edge trends in the US healthcare market, how best to anticipate change in market movements, and how this might be distilled to inform go-to-market commercial strategy for healthcare enterprises. Select companies of interest will be used to demonstrate these points, outlining why these, and other organisations traditionally outside of healthcare, are destined to shape the future.
Learn how your company can adapt to these changes and prepare for US sales success.
If you would like to participate in the full Going Global Module #4 – US – Go-to-Market commercial strategy: Positioning for US sales success find out more and register here.
Date: Tuesday 16 October
Time: 3.45 pm registration, presentation & discussion 4.00 pm – 5.00 pm, followed by networking until 6.00 pm
Venue: PriceWaterhouse Coopers, Level 19, 2 Riverside Quay, Southbank
BioMelbourne Network Members: $65
Non Members: $130
(Prices include GST.)
Note: Participants registered for the Going Global program will receive two registrations for this event.
A full refund is given up to 7 days prior to the event.
No refunds within 7 days of the event.
Visiting US expert:
Dr Caroline Popper, co-founder and President, Popper and Company
Caroline founded Popper and Company with Ken Walz more than fifteen years ago to address inefficiencies in healthcare by helping life science companies develop and commercialize new technology. Today, the members of their growing team leverage their extensive knowledge of the tools and trends shaping all aspects of healthcare market and impacting its participants.
Caroline has more than 25 years of hands-on operating experience within healthcare companies and has managed a wide spectrum of diagnostics, device and drug discovery businesses in both Fortune 500 and start-up settings, at amongst others, Becton Dickinson, bioMerieux, and MDS. Now, at her firm, she combines those experiences with her clinical experience to help clients interpret relevant market forces, develop strategies and create partnerships to thrive in the global changing, and increasingly value-driven, healthcare landscape.
The Going Global Program is supported by:
This event is hosted by: